Characterization of the mode of action of a potent dengue virus capsid inhibitor - Wikidata - awgldk - TriplyDB

Characterization of the mode of action of a potent dengue virus capsid inhibitor

Characterization of the mode of action of a potent dengue virus capsid inhibitor

http://www.wikidata.org/entity/Q30365058

about

Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms Dengue Virus Genome Uncoating Requires Ubiquitination My Cousin, My Enemy: quasispecies suppression of drug resistance Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond Current Status of Dengue Therapeutics Research and Development.Properties and Functions of the Dengue Virus Capsid Protein.A Multiplexed Cell-Based Assay for the Identification of Modulators of Pre-Membrane Processing as a Target against Dengue Virus Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly Suppression of Drug Resistance in Dengue Virus.A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.Dengue Virus Uses a Non-Canonical Function of the Host GBF1-Arf-COPI System for Capsid Protein Accumulation on Lipid Droplets.Antiviral activity of Thiosemicarbazones derived from α-amino acids against Dengue virus.Geometric Defects and Icosahedral Viruses.In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of Hepatitis E virus capsid protein.Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells.The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity.A Reverse Genetics System for Zika Virus Based on a Simple Molecular Cloning Strategy

P2860

Q24570091-3E33E0E8-EEFC-4D2C-AFDB-20B686171AFC Q25242049-C3F7F146-DA9C-4E07-AD8E-B8DD952179B0 Q28076138-BFB23FA5-849C-48AB-A232-D4D71A202759 Q28550932-D7F4E8A7-E038-401A-9CAC-7439D2E95672 Q29994527-E0290549-0EB7-49FD-8835-11B90AFAB7C7 Q33552896-304C0F12-D4E1-4CFD-8CFA-39C0FEE9F3CC Q33637110-06C01238-AA87-43D0-B14D-E04F182E278D Q35569080-D8E62519-69CA-4913-9DCA-77003763CDA1 Q35647755-A58D9CCD-2C02-409F-98CD-8FE09FD4FDF5 Q35758578-3D38D194-CCE5-446D-9B08-A0FBE0AAA6B2 Q35914284-1B224E6E-35FF-4EBE-B7E8-43F4D910B267 Q36431588-13A48529-228D-4E22-86F1-EA926C4025EF Q37415438-8B165CB1-8196-49AA-99BB-B00CE142FD85 Q38156667-3DA9CAA3-437C-4291-AA6B-998C53B55335 Q38544126-08032D84-9DFB-415A-8BDA-1BFDBD714DF3 Q38868883-9AB479A8-6E5B-4FF8-9CE3-8E8EA062624B Q39333066-D2F9ABC8-D540-4611-9529-6C45FA96B808 Q47233096-05627648-1768-4CFD-84BC-38DC51D69FCB Q47240941-400B3654-4B13-4FCC-AE75-55243273F2FE Q54261279-09C5B839-1A6E-4FEB-B5BC-7952085CD4BA Q55084359-9924C329-3E2E-4AED-B79C-E185492FCE2C Q56346410-EC195887-04B5-40A2-8EBF-45334C0F692D

P2860

Characterization of the mode of action of a potent dengue virus capsid inhibitor

http://www.wikidata.org/entity/Q30365058

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@ast

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@en

type

label

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@ast

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@en

prefLabel

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@ast

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@en

P1433

Q30365058-29C0A159-22EE-42B9-A48B-C9F4D586B0A0

P1476

Q30365058-F5E311C3-6F2D-4D69-BF98-9391C6857F26

P2093

Q30365058-602DAA5B-B505-44EB-BE53-8212B259A616

Q30365058-D2AACD80-26DC-4521-AE6D-A91DA5485739

Q30365058-F9AB654A-7E36-487F-8BC0-B66CFDD60981

P2860

Q30365058-044D0C2B-C332-410C-8578-1C8DF75B500C

Q30365058-04D4E4E6-7CD8-4342-92F5-7C3BCEB56695

Q30365058-0560A8DC-AE32-4715-AF7D-3D2BC668B80F

Q30365058-0CB4CD1D-9CB4-44B7-9817-182D7BDC76E0

Q30365058-0EDFA2E3-DE09-4C17-A2A2-B79C42AE570C

Q30365058-12A316B0-FF5F-49EE-B86E-7629111D679D

Q30365058-1534500C-6F28-4047-9DCF-E9D1BB9D3AE5

Q30365058-2296A553-D6BF-401A-B185-6A7E6553DF22

Q30365058-235AAE59-BFAA-49BB-AAA0-0B4933DF5071

Q30365058-24F0AC3D-100A-4F18-8B1F-E164C4612A69

P304

Q30365058-35E98267-391D-436C-9927-B5FB0B4E59BB

P31

Q30365058-9C5543B2-79DF-412E-A5AA-79032064CF0D

P356

Q30365058-E52B7637-7DE7-4806-9CCB-7C7E34782C91

P433

Q30365058-2DFD3CE9-C6A4-4B1B-914A-CEA09C9AFB8C

P478

Q30365058-361EE7C8-0A9C-43AA-A715-458CD5621C95

P50

Q30365058-0DBC8906-701D-485A-BB0D-81C82CC76A8E

Q30365058-0E4118F2-0DE7-42DC-814E-2ECD6CB720A2

Q30365058-123040C8-BCE5-4E09-B63D-AF4BD21AFCF0

Q30365058-669996AF-3ECE-49D1-8192-CD3269F75108

Q30365058-C07F6FFE-6E64-4D6E-A7A7-E44D43156BFF

Q30365058-E063ADB6-EF63-4F92-A7C8-94C62437CAAE

P577

Q30365058-23AED414-13B9-4831-922B-76E24EE15039

P5875

Q30365058-A6079F51-8CEA-400F-8349-ACF3E919C40C

P698

Q30365058-E5D20B48-32C5-4943-B317-51074DC6E521

P921

Q30365058-2EFD6717-82D0-407E-9CCE-ED8AFC514CF5

P932

Q30365058-5DC250F3-2EE6-4C3B-8DA8-FBD9C972C125

P356

P1433

Journal of Virology

P1476

Characterization of the mode of action of a potent dengue virus capsid inhibitor

@en

P2093

Chelsea M Byrd

http://www.w3.org/2001/XMLSchema#string

Eliana G Acosta

http://www.w3.org/2001/XMLSchema#string

Iuni Margaret Laura Trist

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine

The global distribution and burden of dengue

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Architecture and biogenesis of plus-strand RNA virus replication factories

Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells

Nuclear localization of Japanese encephalitis virus core protein enhances viral replication.

trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells.

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

Flavivirus Capsid Is a Dimeric Alpha-Helical Protein

Incorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell Line

P304

11540-11555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01745-14

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Ralf Bartenschlager

Andrea Brancale

Pietro Scaturro

P577

2014-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264201995

http://www.w3.org/2001/XMLSchema#string

P698

25056895

http://www.w3.org/2001/XMLSchema#string

P921

P932

4178822

http://www.w3.org/2001/XMLSchema#string